neostigmine has been researched along with Central Nervous System Disease in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radzimiński, A | 1 |
| Latkowski, B | 1 |
| Duvoisin, RC | 1 |
| Katz, R | 1 |
1 review available for neostigmine and Central Nervous System Disease
| Article | Year |
|---|---|
[Usefulness of electronystagmography in neurologic diagnosis].
Topics: Brain Concussion; Central Nervous System Diseases; Electrooculography; Eye Movements; Fixation, Ocul | 1971 |
1 other study available for neostigmine and Central Nervous System Disease
| Article | Year |
|---|---|
Reversal of central anticholinergic syndrome in man by physostigmine.
Topics: Aged; Ataxia; Central Nervous System Diseases; Child; Cognition Disorders; Delirium; Female; Halluci | 1968 |